000145553 001__ 145553 000145553 005__ 20250908131442.0 000145553 0247_ $$2doi$$a10.3390/endocrines5030020 000145553 0248_ $$2sideral$$a140396 000145553 037__ $$aART-2024-140396 000145553 041__ $$aeng 000145553 100__ $$aKantaras, Paris 000145553 245__ $$aBeverage consumption patterns and their association with metabolic health in adults from families at high risk for type 2 diabetes in Europe—The Feel4Diabetes study 000145553 260__ $$c2024 000145553 5060_ $$aAccess copy available to the general public$$fUnrestricted 000145553 5203_ $$aIn total, 3274 adults (65.2% females) from six European countries were included in this cross-sectional analysis using data from the baseline assessment of the Feel4Diabetes study. Anthropometric, sociodemographic, dietary and behavioral data were assessed, and the existence of metabolic syndrome (MetS) was recorded. Beverage consumption patterns (BCPs) were derived via principal component analysis. Three BCPs were derived explaining 39.5% of the total variation. BCP1 was labeled as “Alcoholic beverage pattern”, which loaded heavily on high consumption of beer/cider, wine and other spirits; BCP2 was labeled as “High in sugars beverage pattern” that was mainly characterized by high consumption of soft drinks with sugar, juice containing sugar and low consumption of water; and BCP3 was labeled as “Healthy beverage pattern” that was mainly characterized by high consumption of water, tea, fruit juice freshly squeezed or prepacked without sugar and low consumption of soft drinks without sugar. After adjusting for various confounders, BCP2 was positively associated with elevated triglycerides (p = 0.001), elevated blood pressure (p = 0.001) elevated fasting glucose (p = 0.008) and the existence of MetS (p = 0.006), while BCP1 was inversely associated with reduced HDL-C (p = 0.005) and BCP3 was inversely associated with elevated blood pressure (p = 0.047). The establishment of policy actions as well as public health nutritional education can contribute to the promotion of a healthy beverage consumption. 000145553 536__ $$9info:eu-repo/grantAgreement/ES/DGA/CP03/2016 000145553 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/ 000145553 592__ $$a0.412$$b2024 000145553 593__ $$aBiochemistry, Genetics and Molecular Biology (miscellaneous)$$c2024$$dQ3 000145553 593__ $$aMedicine (miscellaneous)$$c2024$$dQ3 000145553 593__ $$aEndocrinology, Diabetes and Metabolism$$c2024$$dQ3 000145553 593__ $$aEndocrinology$$c2024$$dQ4 000145553 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion 000145553 700__ $$aMourouti, Niki 000145553 700__ $$aMouratidou, Theodora 000145553 700__ $$aChatzaki, Ekaterini 000145553 700__ $$aKaraglani, Makrina 000145553 700__ $$aIotova, Violeta 000145553 700__ $$aUsheva, Natalya 000145553 700__ $$aRurik, Imre 000145553 700__ $$aTorzsa, Péter 000145553 700__ $$0(orcid)0000-0003-0454-653X$$aMoreno, Luis A.$$uUniversidad de Zaragoza 000145553 700__ $$aLiatis, Stavros 000145553 700__ $$aMakrilakis, Konstantinos 000145553 700__ $$aManios, Yannis 000145553 700__ $$0(orcid)0000-0001-7043-0952$$aCiveira, Fernando$$uUniversidad de Zaragoza 000145553 700__ $$0(orcid)0000-0002-0902-387X$$aBueno, Gloria$$uUniversidad de Zaragoza 000145553 700__ $$0(orcid)0000-0001-6173-5850$$aDe Miguel-Etayo, Pilar$$uUniversidad de Zaragoza 000145553 700__ $$0(orcid)0000-0003-2005-8229$$aGonzález-Gil, Esther M. 000145553 700__ $$aMiguel-Berges, María L. 000145553 700__ $$0(orcid)0000-0002-2956-4219$$aGiménez-Legarre, Natalia$$uUniversidad de Zaragoza 000145553 700__ $$0(orcid)0000-0002-2135-900X$$aFlores-Barrantes, Paloma 000145553 700__ $$0(orcid)0000-0001-8914-0752$$aAyala-Marín, Alelí M. 000145553 700__ $$0(orcid)0000-0001-6899-5938$$aSeral-Cortés, Miguel$$uUniversidad de Zaragoza 000145553 700__ $$aBaila-Rueda, Lucía$$uUniversidad de Zaragoza 000145553 700__ $$aCenarro, Ana 000145553 700__ $$0(orcid)0000-0001-9142-0737$$aJarauta, Estíbaliz$$uUniversidad de Zaragoza 000145553 700__ $$0(orcid)0000-0001-6650-8294$$aMateo-Gallego, Rocío$$uUniversidad de Zaragoza 000145553 7102_ $$11006$$2255$$aUniversidad de Zaragoza$$bDpto. Fisiatría y Enfermería$$cÁrea Enfermería 000145553 7102_ $$11007$$2610$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Medicina 000145553 7102_ $$10$$2X$$aUniversidad de Zaragoza$$bOficina Transf.Result. Invest.$$cArea Admón. OTRI 000145553 7102_ $$11011$$2615$$aUniversidad de Zaragoza$$bDpto. Microb.Ped.Radio.Sal.Pú.$$cÁrea Medic.Prevent.Salud Públ. 000145553 7102_ $$11011$$2670$$aUniversidad de Zaragoza$$bDpto. Microb.Ped.Radio.Sal.Pú.$$cÁrea Pediatría 000145553 773__ $$g5, 3 (2024), 277-289$$pEndocrines (Basel)$$tEndocrines$$x2673-396X 000145553 8564_ $$s458642$$uhttps://zaguan.unizar.es/record/145553/files/texto_completo.pdf$$yVersión publicada 000145553 8564_ $$s2685740$$uhttps://zaguan.unizar.es/record/145553/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada 000145553 909CO $$ooai:zaguan.unizar.es:145553$$particulos$$pdriver 000145553 951__ $$a2025-09-08-12:59:55 000145553 980__ $$aARTICLE